0 items USD 0.00Search
- Did you mean
- rejuvenation idiopathic arthritis
Your search for "Juvenile idiopathic arthritis" gave back 1679 results.
IL-6R agonists are a class of compounds or biomolecules that can promote the activation of interleukin-6 receptor (IL-6R) or enhance its signaling...
颁补迟补濒辞驳:听
LPI
July 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 4,900.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 5,900.00
The biologics used in Anti-inflammatory treatment 鈥� abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 4,900.00
Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and...
颁补迟补濒辞驳:听
LPI
July 2024
Price: USD 3,660.00
Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
IL-6R agonists are a class of compounds or biomolecules that can promote the activation of interleukin-6 receptor (IL-6R) or enhance its signaling...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
IL-6R agonists are a class of compounds or biomolecules that can promote the activation of interleukin-6 receptor (IL-6R) or enhance its signaling...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
The global Rofecoxib market size was valued at US$ million in 2023. With growing demand in downstream market, the Rofecoxib is forecast to a...
颁补迟补濒辞驳:听
LPI
November 2024
Price: USD 3,660.00
The global Rofecoxib market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
颁补迟补濒辞驳:听
GIR
June 2024
Price: USD 3,480.00
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid...
颁补迟补濒辞驳:听
MRRPB5
March 2024
Price: USD 2,900.00
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 4,900.00
Rare inflammatory disease treatment refers to specialized therapies for uncommon chronic inflammatory conditions caused by immune system...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 2,900.00
Rare autoinflammatory diseases drugs are medications designed to treat conditions where the body's immune system mistakenly attacks itself,...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 2,900.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
听
